Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DXN LIMITED Capital/Financing Update 2019

Oct 10, 2019

64806_rns_2019-10-10_39182ade-5a8b-400a-8cdf-cb46204fcbaa.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

DXN Limited

ABN

46 620 888 548

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or
to be issued (if known) or
maximum number which may
be issued
3
Principal
terms
of
the
+securities
(e.g.
if
options,
exercise price and expiry date; if
partly
paid
+securities,
the
amount outstanding and due
dates
for
payment;
if
+convertible
securities,
the
conversion price and dates for
conversion)
(a) Fully Paid Ordinary Shares
(b) Listed Options
(c) Listed Options
(a) 90,567,933
(b) 90,567,933
(c) 15,000,000
(a) Fully Paid
(b) Exercisable at $0.10 per Option on or
before the date which is 12 months from
the date of issue
(c) Exercisable at $0.10 per Option on or
before the date which is 12 months from
the date of issue
  • 4 Do the[+] securities rank equally (a) Yes in all respects from the[+] issue (b) No, however on exercise of the options date with an existing[+] class of into fully paid ordinary shares, the issued quoted[+] securities? shares will rank equally with existing fully paid ordinary shares currently on issue in

  • If the additional[+] securities do the Company. not rank equally, please state: (c) No, however on exercise of the options • the date from which they do into fully paid ordinary shares, the issued • the extent to which they shares will rank equally with existing fully participate for the next paid ordinary shares currently on issue in dividend, (in the case of a the Company. trust, distribution) or interest payment

  • • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

  • 5 Issue price or consideration (a) $0.055 per fully paid ordinary share (b) Free-attaching to the shares set out in (a) on the basis of 1 option for every 1 share applied for and issued

  • (c) To be issued as part of lead manager and underwriter services provided by Pinnacle Corporate Finance Pty Ltd

  • 6 Purpose of the issue Pursuant to rights issue announced by the Company (If issued as consideration for on 9 October 2019 and prospectus announced by the acquisition of assets, clearly the Company on 11 October 2019 identify those assets)

6a Is the entity an[+] eligible entity Yes that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the[+] securities the subject of this Appendix 3B , and comply with section 6i 6b The date the security holder 29 November 2018 resolution under rule 7.1A was passed 6c Number of[+] securities issued 15,000,000 Listed Options without security holder approval under rule 7.1

  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

6d
Number of+securities issued
with security holder approval
under rule 7.1A
6e
Number of+securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)
6f
Number of+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which
valuation
of
consideration was released to
ASX Market Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for a
pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
Nil
Nil
(a) 90,567,933 Fully Paid Ordinary Shares
(b) 90,567,933 Listed Options

Not applicable
Not applicable
Rule 7.1 – 53,075,850
Rule 7.1A - 45,383,966
11 November 2019 (subject to change in compliance
with the ASX Listing Rules)

8 Number and +class of all +securities quoted on ASX ( including the +securities in section 2 if applicable)

Number +Class
372,352,165
82,994,923
105,567,933
Fully Paid Ordinary Shares
Options exercisable at $0.10
on or before 13 May 2020
Options exercisable at $0.10
on or before the date which
is 12 months from the date
of issue
9
Number
and
+class
of
all
+securities not quoted on ASX
(_including_the
+securities in
section 2 if applicable)
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
Number +Class
75,487,500
5,000,000
32,500,000
609,375
6,218,750
8,168,772
100
Fully Paid Ordinary Shares
not quoted until 24 months
from date of quotation
Fully Paid Ordinary Shares
not quoted until 36 months
from date the Company is
admitted to the Official List
Unlisted Options exercisable
at $0.30 on or before 30
November 2020 not quoted
until 24 months from date
of quotation
Unlisted Options exercisable
at $0.30 on or before 5 April
2021 not quoted until 24
months
from
date
of
quotation
Unlisted Options exercisable
at $0.30 on or before 5 April
2021
Performance Rights, subject
to
vesting
conditions,
expiring on various dates
from 24 December 2019 to
26 June 2022
Convertible Notes
Not applicable

Part 2 - Pro rata issue

Part 2 - Pro rata issue
11
Is
security
holder
approval
required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities
will be offered

No
Non-renounceable

1 Share for every 4 Shares held, with 1 free-
attaching listed Option for every 1 share applied
for and issued
  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

14
+Class of+securities to which the
offer relates
15
+Record
date
to
determine
entitlements
16
Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?
17
Policy for deciding entitlements
in relation to fractions
18
Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee
or commission
22
Names of any brokers to the
issue
23
Fee or commission payable to
the broker to the issue
24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25
If the issue is contingent on
security holders’ approval, the
date of the meeting
Fully paid ordinary shares
17 October 2019
No
Rounded up
All countries except Australia, New Zealand and
Singapore
4 November 2019
Pinnacle Corporate Finance Pty Ltd
5% of underwritten amount
Pinnacle Corporate Finance Pty Ltd (Lead Manager)
and Lucerne Investment Partners Pty Ltd (Co-
Manager)
6% (1% management fee and 5% underwriting fee)
of the underwritten amount to Pinnacle Corporate
Finance Pty Ltd. Any fees payable to Lucerne
Investment Partners Pty Ltd will be paid by
Pinnacle Corporate Finance Pty Ltd out of the 1%
management fee and 5% underwritingfee
As per Prospectus
Not applicable
26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
27
If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell
their entitlements_in full_through
a broker?
31
How do security holders sell_part_
of their entitlements through a
broker
and
accept
for
the
balance?
32
How do security holders dispose
of their entitlements (except by
sale through a broker)?
33
+Issue date
21 October 2019
11 October 2019
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
11 November 2019

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one )

(a) +Securities described in Part 1

(b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

  • 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

  • 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

  • 38 Number of[+] securities for which +quotation is sought

  • 39 +Class of +securities for which quotation is sought

  • 40 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

  • 41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security)

Number +Class

42 Number and +class of all +securities quoted on ASX ( including the[+] securities in clause 38)

  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:

==> picture [114 x 48] intentionally omitted <==

Date: 11 October 2019

Company secretary

Print name: George Lazarou

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Insert number of fully paid[+] ordinary 182,312,501 securities on issue 12 months before the + issue date or date of agreement to issue

Add the following:

  • Number of fully paid[+] ordinary securities issued in that 12 month period under an 1,000,008 – 3 October 2019

  • exception in rule 7.2 90,567,933 – 11 October 2019

  • • Number of fully paid[+] ordinary securities 12,969,512 – 21 January 2019

  • issued in that 12 month period with 165,989,711 – 13 & 15 May 2019

  • shareholder approval

  • Number of partly paid[+] ordinary securities that became fully paid in that 12 month period

Note:

  • Include only ordinary securities here – other classes of equity securities cannot be added

  • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

  • It may be useful to set out issues of securities on different dates as separate line items

Subtract the number of fully paid[+] ordinary Nil securities cancelled during that 12 month period “A” 453,839,665

  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A” Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 68,075,950
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1
that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
100 Convertible Notes – 11 October
15,000,000 Listed Options – 11 October
2019
“C” 15,000,100
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
68,075,950
Subtract“C”
Note: number must be same as shown in
Step 3
15,000,100
Total[“A” x 0.15] – “C” 53,075,850
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 453,839,665 Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 45,383,966

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of[+] equity securities issued Nil or agreed to be issued in that 12 month period under rule 7.1A

Notes:

  • This applies to equity securities – not just ordinary securities

  • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

  • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

  • It may be useful to set out issues of securities on different dates as separate line items

  • “E” Nil

  • See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
45,383,966
Subtract“E”
Note: number must be same as shown in
Step 3
Nil
Total[“A” x 0.10] – “E” 45,383,966
Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

Appendix 3B Page 13

04/03/2013